Our investigational therapies are designed to produce a completely individualized response, specific to the patient and their cancer for long-lasting protection
Our viral immunotherapies are being designed to have favorable benefit-to-risk profiles, in an effort to ensure patients have efficacious and well tolerated treatments across disease stages
